Literature DB >> 6161957

Immune and enzyme histochemical studies of a human hepatocellular carcinoma cell line producing hepatitis B surface antigen.

M A Gerber, E Garfinkel, S Z Hirschman, S N Thung, T Panagiotatos.   

Abstract

PLC/PRF/5, a tissue culture cell line derived from a human hepatocellular carcinoma and producing hepatitis B surface antigen (HBsAg), was studied by immune and enzyme histochemical techniques. HBsAg was demonstrated in the cytoplasm and on the surface of tumor cells. The percentage of HBsAg-positive cells in subculture increased with time until almost all cells expressed HBsAg when the monolayer reached confluence. Similar patterns were found for alpha 1-anti-trypsin and carcino-embryonic antigen, whereas alpha-fetoprotein was observed only in small foci of cells. Hepatitis B core antigen and albumin were not detected. gamma-Glutamyl transferase activity was markedly increased in the tumor cells, whereas adenosine triphosphatase and glucose-6-phosphatase activities were not demonstrable. Patterns of antigenic expression and enzyme phenotype of PLC/PRF/5 cells show remarkable resemblance to those observed in vivo in human hepatocellular carcinoma. Therefore, this cell line may be a useful model to study the control and modulation of both oncofetal antigens and HBsAg.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6161957

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

Review 1.  Hepatitis B virus components produced by the human hepatoma cell line PLC/PRF/5: do they indicate virus propagation? Brief review.

Authors:  O Marquardt
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

2.  Expression of HLA class I antigens on hepatocytes in liver disease.

Authors:  T Fukusato; M A Gerber; S N Thung; S Ferrone; F Schaffner
Journal:  Am J Pathol       Date:  1986-05       Impact factor: 4.307

3.  Amplification of expression of hepatitis B surface antigen in 3T3 cells cotransfected with a dominant-acting gene and cloned viral DNA.

Authors:  J K Christman; M Gerber; P M Price; C Flordellis; J Edelman; G Acs
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

4.  Characterization and demonstration of human liver-specific protein (LSP) and apo-LSP.

Authors:  N Lebwohl; M A Gerber
Journal:  Clin Exp Immunol       Date:  1981-11       Impact factor: 4.330

5.  Predicted secondary structure similarity in the absence of primary amino acid sequence homology: hepatitis B virus open reading frames.

Authors:  E Schaeffer; J J Sninsky
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

6.  Selecting binding and complement-mediated lysis of human hepatoma cells (PLC/PRF/5) in culture by monoclonal antibodies to hepatitis B surface antigen.

Authors:  D Shouval; J R Wands; V R Zurawski; K J Isselbacher; D A Shafritz
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

7.  Establishment and characterization of a new human hepatocellular carcinoma cell line.

Authors:  L He; K J Isselbacher; J R Wands; H M Goodman; C Shih; A Quaroni
Journal:  In Vitro       Date:  1984-06

8.  Physicochemical and immunohistological studies of a sulfobromophthalein- and bilirubin-binding protein from rat liver plasma membranes.

Authors:  W Stremmel; M A Gerber; V Glezerov; S N Thung; S Kochwa; P D Berk
Journal:  J Clin Invest       Date:  1983-06       Impact factor: 14.808

9.  Role in nude mice of interferon and natural killer cells in inhibiting the tumorigenicity of human hepatocellular carcinoma cells infected with hepatitis B virus.

Authors:  D Shouval; B Rager-Zisman; P Quan; D A Shafritz; B R Bloom; L M Reid
Journal:  J Clin Invest       Date:  1983-08       Impact factor: 14.808

10.  A new human hepatocellular carcinoma cell line (KYN-1) with a transformation to adenocarcinoma.

Authors:  H Yano; M Kojiro; T Nakashima
Journal:  In Vitro Cell Dev Biol       Date:  1986-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.